Overview
Reig Jofre is a pharmaceutical company founded in Barcelona in 1929, engaged in the research, development, manufacture and marketing of medicines and dietary supplements. Its products include sterile and lyophilized injectable medicines, penicillin antibiotics, specialist products in orthopedics and dermatology, and OTC medicines and supplements.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 10 days early. 3 of 5 audited by a statutory auditor.
- 202510/07/2026
- 202415/07/2025
- 202325/06/2024
- 202202/07/2023
- 202105/07/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Infusion medicines
- Antifungal medicines
- Anticancer medicines
Website technology
- Website
- WordPress
Trademarks
Reig Jofre holds 3 active trademarks registered with the Polish Patent Office. The first mark was filed in 2013.
| Mark | Protected until | |
|---|---|---|
| Hydrosil - Przyspiesza gojenie i działa przeciwbólowo(word) | May 13, 2034 | |
| Hydrosil leczenie oparzeń(word) | Dec 12, 2033 | |
| Hydrosil leczenie ran(word) | Dec 12, 2033 |
Authorized Representatives
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Laboratorio Reig Jofre S.A. | 5,000 | $135,062.13 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-02-26.
03 1090 1056 0000 0001 5638 8726- 49 1090 1056 0000 0001 4755 1489
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Delfarmasp. z o.o. | $63,830,205.42 | delfarma.pl | ||
| Optifarmasp. z o.o. + limited partnership | $29,560,928.95 | optifarma.com | ||
| Biuro Handlowe Elroy Krystyna Maria Rojek Leszek Michał Rojeksp. j. | $24,621,042.50 | elroy.pl | ||
| Polski Lek - Dystrybucjasp. z o.o. | $17,865,782.64 | polskilek.pl | ||
| Dicofarm Polskasp. z o.o. | $9,478,812.54 | dicofarm.pl | ||
| REJAsp. z o.o. | $7,197,816.28 | reja.com.pl | ||
| Fortis Pharmaceuticalssp. z o.o. | $6,911,557.57 | fortispharmaceuticals.pl | ||
| Steriwundsp. z o.o. | $2,832,891.51 | steriwund.pl | ||
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu |
Change history
| Date | Event | |
|---|---|---|
| 2021-05-21 | Share capital increase (100,000.00 PLN → 500,000.00 PLN) | |
| 2021-02-11 | Entered in the register |
FAQ
Last updated: 2026-10-07